UPDATE : Thursday, April 9, 2020
상단여백
Will Korean COVID-19 patients get to use remdesivir for compassionate use?
With new outbreaks of the novel coronavirus (COVID-19) spiked in Korea with...
by Kim Yun-mi  |  2020-02-24 17:41
라인
Local researchers find new cause of Parkinson’s disease
A joint research team has discovered that if the function of a causative ge...
by Shim Hyun-tai  |  2020-02-21 18:25
라인
Labor group slams Fresenius for allegedly breaching labor law
The Korean offshoot of Germany-based Fresenius Medical Care has violated em...
by Kim Yun-mi  |  2020-02-21 16:39
라인
‘Favipiravir not approved as new coronavirus drug yet’
Some local news reports said -- mistakenly -- favipiravir, an experimental ...
by Kim Yun-mi  |  2020-02-21 12:08
라인
Theragen Etex marked record-high sales, net profits in 2019
Theragen Etex said Thursday it hit record-high sales of 138.7 billion won (...
by Lee Han-soo  |  2020-02-20 18:48
라인
Regulator OKs Pfizer's Vizimpro as 1st-line treatment of mutated lung cancer
Pfizer Korea said Thursday that the Ministry of Food and Drug Safety has ap...
by Shim Hyun-tai  |  2020-02-20 18:47
라인
Daewoong’s Nabota gets item license in Brazil
Daewoong Pharmaceutical said Thursday that its botulinum product, Nabota, h...
by Shim Hyun-tai  |  2020-02-20 16:11
라인
Drugmakers rush to roll out famotidine to replace ranitidine
Local pharmaceutical companies are quickly releasing medicines containing f...
by Jeong Sae-im  |  2020-02-18 15:07
라인
Medytox's Meditoxin gets new indication for cervical dystonia
Medytox said Tuesday that its botulinum toxin preparation, Meditoxin, has r...
by Shim Hyun-tai  |  2020-02-18 15:06
라인
JW wins US patent for world’s 1st multi-biomarker diagnostic kit
JW Holdings said Monday that it has obtained a patent in the United States ...
by Shim Hyun-tai  |  2020-02-17 17:54
라인
Genexine’s US affiliate gets FDA nod for immune booster trial
NeoImmuneTech, Genexine's affiliate, received approval from the U.S. Fo...
by Shim Hyun-tai  |  2020-02-17 12:46
라인
Helixmith gets mixed results from p3-1 trials of gene therapy
Helixmith said Friday that the clinical trial phase 3-1 result of Engensis ...
by Shim Hyun-tai  |  2020-02-14 18:12
라인
Eisai to pull out antiobesity drug Belviq from US market
Eisai Pharmaceutical, a Japan-based multinational drug firm, has decided to...
by Lee Han-soo  |  2020-02-14 16:38
라인
Daewoong’s sales reached ₩1 trillion milestone in 2019
Daewoong Pharmaceutical said that its sales exceeded 1 trillion won ($845.8...
by Lee Han-soo  |  2020-02-14 14:33
라인
JW Pharmaceutical turns to loss on reduced sales of nutrients
JW Pharmaceutical said it reported operating loss in 2019, turning from an ...
by Jeong Sae-im  |  2020-02-14 12:03
라인
Mediforum turned around to net profit in 2019
Mediforum, a pharmaceutical specialized in developing degenerative brain di...
by Shim Hyun-tai  |  2020-02-13 17:43
라인
Bukwang's dyskinesia treatment gets FDA nod for p 2 trials
The U.S. Food and Drug Administration has recently approved the phase 2 cli...
by Shim Hyun-tai  |  2020-02-13 14:22
라인
Dong-A ST posts robust profit in 2019
Dong-A ST said Thursday that it recorded sales of 612.2 billion won ($518.2...
by Lee Han-soo  |  2020-02-13 14:20
라인
ISU’s US partner releases clinical trial results of new hemophilia treatment
ISU Abxis, an orphan drug developer, said Wednesday that its U.S. partner, ...
by Shim Hyun-tai  |  2020-02-13 11:18
라인
SK Plasma to enter ME market with self-developed tech
SK Plasma has signed a memorandum of understanding with Arab Company for Dr...
by Shim Hyun-tai  |  2020-02-12 17:16
여백
여백
여백
여백
Back to Top